Prostate cancer genes. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Neoplastic Stem Cells Chromosomes, Human, Pair 8 Seminal Vesicles Cell Line Rectum Stromal Cells Neoplastic Cells, Circulating

Organisms6

Mice, Nude Adenoviridae Mice, SCID Mice, Inbred BALB C Mice, Transgenic Mice, Inbred C57BL

Diseases36

Prostatic Neoplasms Prostatic Hyperplasia Neoplasms Neoplasms, Hormone-Dependent Adenocarcinoma Neoplasm Metastasis Disease Progression Prostatic Intraepithelial Neoplasia Breast Neoplasms Neoplasm Invasiveness Genetic Predisposition to Disease Bone Neoplasms Ovarian Neoplasms Lung Neoplasms Carcinoma Colonic Neoplasms Neoplasm Recurrence, Local Cell Transformation, Neoplastic Prostatic Neoplasms, Castration-Resistant Stomach Neoplasms Pancreatic Neoplasms Colorectal Neoplasms Prostatic Diseases Neovascularization, Pathologic Prostatitis Disease Models, Animal Urinary Bladder Neoplasms Gliosarcoma Neoplastic Syndromes, Hereditary Carcinoma, Squamous Cell Carcinogenesis Uterine Cervical Neoplasms Neoplasms, Experimental Carcinoma, Non-Small-Cell Lung Neoplastic Cells, Circulating Liver Neoplasms

Chemicals and Drugs68

Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Tumor Markers, Biological Neoplasm Proteins Tosyl Compounds Antineoplastic Agents Antineoplastic Agents, Hormonal Androgen Receptor Antagonists RNA, Messenger Anilides Dihydrotestosterone Finasteride RNA, Small Interfering DNA, Neoplasm Metribolone Flutamide PTEN Phosphohydrolase Anticarcinogenic Agents Cancer Vaccines Taxoids Glutamate Carboxypeptidase II 5-alpha Reductase Inhibitors Prodrugs Tumor Suppressor Proteins Transcription Factors Testosterone Congeners Tumor Suppressor Protein p53 MicroRNAs Antineoplastic Agents, Phytogenic RNA, Neoplasm Antigens, Neoplasm Androstenols Testosterone 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Azasteroids Phenylthiohydantoin Nitriles Proto-Oncogene Proteins c-akt DNA-Binding Proteins Racemases and Epimerases DNA Primers Cholestenone 5 alpha-Reductase Proto-Oncogene Proteins Estramustine Leuprolide Goserelin Receptor, erbB-2 Nuclear Proteins Glutathione S-Transferase pi Thymidine Kinase BRCA2 Protein Receptors, Estrogen Ganciclovir Inhibitor of Apoptosis Proteins Enzyme Inhibitors Antibodies, Monoclonal Prostatic Secretory Proteins Genetic Markers Coxsackie and Adenovirus Receptor-Like Membrane Protein Androgen-Binding Protein Proto-Oncogene Proteins c-bcl-2 Kallikreins BRCA1 Protein Steroid 17-alpha-Hydroxylase Paclitaxel Cell Cycle Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment74

Genetic Therapy Prostatectomy Orchiectomy Early Detection of Cancer Gene Expression Profiling Xenograft Model Antitumor Assays Neoplasm Grading Reverse Transcriptase Polymerase Chain Reaction Neoplasm Transplantation Neoplasm Staging Prognosis Transplantation, Heterologous Digital Rectal Examination Risk Factors Blotting, Western Immunohistochemistry Oligonucleotide Array Sequence Analysis Case-Control Studies Transfection Transurethral Resection of Prostate Risk Sensitivity and Specificity Prospective Studies Follow-Up Studies Biopsy Survival Rate Risk Assessment Survival Analysis Retrospective Studies Combined Modality Therapy Biopsy, Needle Cohort Studies Odds Ratio Treatment Outcome Brachytherapy Polymerase Chain Reaction Gene Transfer Techniques Incidence Tumor Burden Reproducibility of Results Tissue Array Analysis Disease-Free Survival Castration SEER Program Antineoplastic Combined Chemotherapy Protocols Multivariate Analysis Registries Predictive Value of Tests DNA Mutational Analysis Radiotherapy Models, Biological Flow Cytometry Genetic Testing Nomograms Kaplan-Meier Estimate Drug Screening Assays, Antitumor Logistic Models Molecular Targeted Therapy Radiotherapy Dosage Disease Models, Animal Radiotherapy, Conformal Questionnaires In Situ Hybridization, Fluorescence Mass Screening Gene Knockdown Techniques Confidence Intervals Clinical Trials as Topic Immunotherapy Immunoenzyme Techniques Neoplasms, Experimental Transduction, Genetic Radiotherapy, Intensity-Modulated Cluster Analysis Radiotherapy Planning, Computer-Assisted

Psychiatry and Psychology1

Phenomena and Processes53

Genes, Neoplasm Gene Expression Regulation, Neoplastic Apoptosis Genetic Predisposition to Disease Cell Proliferation Genetic Vectors Mutation Signal Transduction Transfection Genes, Tumor Suppressor Cell Division Cell Survival Promoter Regions, Genetic Risk Down-Regulation Genotype Cell Growth Processes Sensitivity and Specificity Drug Resistance, Neoplasm DNA Methylation Genes, Transgenic, Suicide Oncogenes Cell Cycle Gene Fusion Odds Ratio Gene Silencing Time Factors Cell Movement Polymorphism, Genetic RNA Interference Gene Expression Dose-Response Relationship, Drug Base Sequence Up-Regulation Genes, BRCA1 Polymorphism, Single Nucleotide Nomograms Chromosomes, Human, Pair 8 Alleles Transcription, Genetic Genome, Human Gene Regulatory Networks Germ-Line Mutation Genes, p53 Phosphorylation Algorithms Diet Phenotype Genes, BRCA2 Epigenesis, Genetic Transduction, Genetic Genetic Markers Loss of Heterozygosity

Disciplines and Occupations4

Immunohistochemistry Genomics Computational Biology Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science12

Survival Rate Incidence Base Sequence SEER Program Registries Molecular Sequence Data Radiotherapy, Conformal Questionnaires Algorithms Databases, Genetic Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted

Named Groups3

European Continental Ancestry Group African Americans Survivors

Health Care32

Risk Factors Watchful Waiting Case-Control Studies Risk Sensitivity and Specificity Prospective Studies Follow-Up Studies Survival Rate Risk Assessment Survival Analysis Retrospective Studies Cohort Studies Odds Ratio Treatment Outcome Incidence Reproducibility of Results Disease-Free Survival National Cancer Institute (U.S.)SEER Program Multivariate Analysis Age Factors Registries Predictive Value of Tests Genetic Testing Nomograms Kaplan-Meier Estimate Logistic Models Questionnaires Mass Screening Confidence Intervals Clinical Trials as Topic Cluster Analysis

Geographicals2

United States Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prostatic Neoplasms Genetic Therapy Prostate Prostate-Specific Antigen Cell Line, Tumor Genes, Neoplasm Receptors, Androgen Androgens Androgen Antagonists Gene Expression Regulation, Neoplastic Prostatectomy Prostatic Hyperplasia Neoplasms Mice, Nude Orchiectomy Neoplasms, Hormone-Dependent Tumor Markers, Biological Adenocarcinoma Early Detection of Cancer Neoplasm Metastasis Disease Progression Tumor Cells, Cultured Prostatic Intraepithelial Neoplasia Gene Expression Profiling Neoplasm Proteins Breast Neoplasms Apoptosis Tosyl Compounds Neoplasm Invasiveness Genetic Predisposition to Disease Cell Proliferation Xenograft Model Antitumor Assays Bone Neoplasms Antineoplastic Agents Neoplasm Grading Reverse Transcriptase Polymerase Chain Reaction Neoplasm Transplantation Adenoviridae Neoplasm Staging Prognosis Antineoplastic Agents, Hormonal Genetic Vectors Androgen Receptor Antagonists Transplantation, Heterologous RNA, Messenger Digital Rectal Examination Ovarian Neoplasms Anilides Risk Factors Mutation Lung Neoplasms Blotting, Western Watchful Waiting Immunohistochemistry Dihydrotestosterone Carcinoma Oligonucleotide Array Sequence Analysis Signal Transduction Finasteride RNA, Small Interfering Case-Control Studies Colonic Neoplasms DNA, Neoplasm Transfection Genes, Tumor Suppressor Cell Division Mice, SCID Metribolone Transurethral Resection of Prostate Cell Survival Promoter Regions, Genetic Risk Down-Regulation Genotype Cell Growth Processes Neoplasm Recurrence, Local Sensitivity and Specificity Prospective Studies Follow-Up Studies Cell Transformation, Neoplastic Drug Resistance, Neoplasm Prostatic Neoplasms, Castration-Resistant Flutamide DNA Methylation PTEN Phosphohydrolase Biopsy Survival Rate Risk Assessment Anticarcinogenic Agents Survival Analysis Retrospective Studies Cancer Vaccines Genes, Transgenic, Suicide United States Combined Modality Therapy Taxoids Glutamate Carboxypeptidase II Stomach Neoplasms Oncogenes Biopsy, Needle

No FAQ available that match "prostate cancer genes"